VIM and ovarian neoplasm: Ovarian tumors in mice treated with the SLN-STAT3 ODN-decoy had reduced potential for invasion due to the downregulation of VEGF, MMP9, CDH2, and Vimentin (VIM) and elevated levels of CDH1.